24312 Investors following Sun Pharma. Share this News with them.
0
Like this story, share it with millions of investors on M3
Sun Pharma gets approval for generic Gemzar injection
Sun Pharmaceutical Industries Ltd. announced that USFDA has granted tentative approval for the Company’s Abbreviated New Drug Application for its generic version of Eli Lilly and Co’s Gemzar®, gemcitabine injection.
Sun Pharmaceutical Industries Ltd. announced that USFDA has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) for its generic version of Eli Lilly and Co's Gemzar®, gemcitabine injection.
These generic gemcitabine injections are therapeutic equivalents of Eli Lilly and Co's Gemzar® injections available in two strengths: 200 mg and 1 g single use vial. These strengths of gemcitabine injections have annual sales of approximately USD 680 million in the US.
Gemcitabine is an anticancer, used singly or in combination with other anticancer agents.
|
Budget: 2008, 2009, 2010, 2011, 2012 |
Intuit Money Manager |
RBI Credit Policy | Union Budget | Budget 2012
| Economic Survey
| Railway Budget
| Financial Glossary
|
Message Board |
Moneybhai |
Connect.in.com |
Business Yellow Pages |
India's Premiere Technology Guide | History India
| Up Polls | Latest News
| Uninor | Aurobindo Pharma | Tata Steel | Vodafone Essar | Reliance Industries | Vodafone | Search Engines | Montek Singh Ahluwalia | Reliance Communications | National missile defense 
